Cardiovascular consequences of metabolic syndrome

Johnathan D. Tune, Adam G. Goodwill, Daniel J. Sassoon, Kieren J. Mather

Research output: Contribution to journalReview articlepeer-review

230 Scopus citations


The metabolic syndrome (MetS) is defined as the concurrence of obesity-associated cardiovascular risk factors including abdominal obesity, impaired glucose tolerance, hypertriglyceridemia, decreased HDL cholesterol, and/or hypertension. Earlier conceptualizations of the MetS focused on insulin resistance as a core feature, and it is clearly coincident with the above list of features. Each component of the MetS is an independent risk factor for cardiovascular disease and the combination of these risk factors elevates rates and severity of cardiovascular disease, related to a spectrum of cardiovascular conditions including microvascular dysfunction, coronary atherosclerosis and calcification, cardiac dysfunction, myocardial infarction, and heart failure. While advances in understanding the etiology and consequences of this complex disorder have been made, the underlying pathophysiological mechanisms remain incompletely understood, and it is unclear how these concurrent risk factors conspire to produce the variety of obesity-associated adverse cardiovascular diseases. In this review, we highlight current knowledge regarding the pathophysiological consequences of obesity and the MetS on cardiovascular function and disease, including considerations of potential physiological and molecular mechanisms that may contribute to these adverse outcomes.

Original languageEnglish
Pages (from-to)57-70
Number of pages14
JournalTranslational Research
StatePublished - 1 May 2017


Dive into the research topics of 'Cardiovascular consequences of metabolic syndrome'. Together they form a unique fingerprint.

Cite this